U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875478) titled 'A Database For The Collection Of Clinical, Laboratory, And Treatment Data From Patients With Factor X Deficiency To Define The Natural History Of The Disease And Improve Patient Management' on Oct. 08.

Brief Summary: Factor X deficiency is one of the most severe rare bleeding disorders and may lead to serious spontaneous hemorrhages, particularly in patients with severe congenital forms. Acquired FX deficiency is even rarer, most frequently associated with AL amyloidosis, and remains poorly characterized. Establishing a comprehensive patient registry is essential to improve understanding of disease epidemiology, clinical manifestati...